Gene Mutations in Leukemia Reshape 3D DNA Structure, Study Finds
Researchers have discovered that common mutations in acute myeloid leukemia disrupt the three-dimensional folding of DNA, driving distinct patterns of gene activity inside cancer cells.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- IDH1 and DNMT3A mutations alter the three-dimensional spatial arrangement of DNA in acute myeloid leukemia cells.
- Changes in DNA methylation at CTCF-binding sites disrupt normal loop formation, driving distinct patterns of altered gene activity.
- The early-stage findings from cell models and patient samples offer new insights into leukemia biology but do not yet alter current treatment protocols.
A joint study published in the journal Leukemia by researchers from Kiel University, Charité—Universitätsmedizin Berlin, the UKSH, and the Max Planck Institute for Molecular Genetics revealed that specific gene mutations in acute myeloid leukemia alter the three-dimensional architecture of DNA. Led by Professor Claudia Baldus and Professor Malte Spielmann, the research team identified that common mutations in the IDH1 and DNMT3A genes disrupt genomic folding, altering cell signaling and gene activity.
In healthy individuals, myeloid precursor cells in the bone marrow develop into red blood cells, platelets, and white blood cells through strictly regulated processes. In acute myeloid leukemia, genetic changes cause these precursor cells to replicate uncontrollably, displacing healthy cells and compromising blood system function. The investigation showed that IDH1 and DNMT3A mutations alter chemical methylation at CTCF-protein binding sites, preventing normal DNA loop formation and reorganizing the genome's spatial structure.
The study's first author, Dr. Sophie Steinhäuser, noted that each mutation type generates its own unique 3D structural signature. Using a newly developed analytical technique, co-author Dr. Varun Sreenivasan and the research team were able to map thousands of altered DNA loops in both cell models and patient samples, correlating these structural shifts directly with altered gene expression.
What to know: These findings reflect early-stage laboratory research examining cellular mechanisms. While the study explains how genomic folding may shape blood cancer characteristics, it does not offer immediate medical treatments or diagnostic tools. Readers seeking personal medical advice regarding blood disorders or leukemia risk should consult a healthcare professional.
Source Medical Xpress — medicalxpress.com/news/2026-11-spatial-dna-characteristics-blood-cancer… ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.